Sg3 Management, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $446,000 - $747,800	20,000 New	20,000 $639,000
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $385,200 - $533,850	-15,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$24.9 - $40.26 $373,500 - $603,900	15,000 New	15,000 $439,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $389,400 - $508,500	-10,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $3.5 Million - $5.92 Million	-92,900 Reduced 90.28%	10,000 $433,000
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $5.43 Million - $7.67 Million	102,900 New	102,900 $5.67 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.